Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004973

Chief Financial Officer sold 50,000 shares at an average $67.33 ($3,366,555)

  • Chief Financial Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2021-01-20 Option exercise +50,000 $6.32 $316,000 51,000 D: show line 1 in the form
Cohen Chad M Chief Financial Officer 2021-01-20 Sale −11,050 $66.82 $738,361 39,950 D: show line 2 in the form
Cohen Chad M Chief Financial Officer 2021-01-20 Sale −33,938 $67.35 $2,285,724 6,012 D: show line 3 in the form
Cohen Chad M Chief Financial Officer 2021-01-20 Sale −5,012 $68.33 $342,470 1,000 D: show line 4 in the form
Open-market sales · 50,000 sh · avg $67.33 · $3,366,555

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2021-01-20 Option exercise · Stock Option (Right to Buy) −50,000 265,000 D: show line 5 in the form
Loading xslF345X03/doc4.xml…